U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785492) titled 'Artificial Intelligence Support for Stroke' on Aug. 15.
Brief Summary: This study investigates whether an AI-assisted decision support tool, compared with standard care, increases the proportion of acute ischemic stroke patients receiving intravenous thrombolysis within 24 hours of symptom onset at a primary hospital in China, while also evaluating its impact on clinical outcomes, treatment timelines, and safety.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Ischemic Stroke, Acute
Intervention:
OTHER: AI-assisted thrombolysis decision support
The AI-assisted thrombolysis decision support tool is used by att...